Frank J. Fabio
Financieel Directeur/CFO bij CERES VENTURES, INC.
Actieve functies van Frank J. Fabio
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CERES VENTURES, INC. | Financieel Directeur/CFO | 29-04-2013 | - |
Loopbaan van Frank J. Fabio
Eerdere bekende functies van Frank J. Fabio
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Financieel Directeur/CFO | 12-09-2008 | 09-01-2009 |
Bedrijfssecretaris | 12-09-2008 | 09-01-2009 | |
RENOVACARE, INC. | Financieel Directeur/CFO | 12-09-2008 | 09-01-2009 |
Bedrijfssecretaris | 12-09-2008 | 09-01-2009 | |
SOLARWINDOW TECHNOLOGIES, INC. | Financieel Directeur/CFO | 09-09-2008 | 09-01-2009 |
Bedrijfssecretaris | 09-09-2008 | 09-01-2009 | |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Financieel Directeur/CFO | - | 14-11-2007 |
Bedrijfssecretaris | - | 14-11-2007 |
Opleiding van Frank J. Fabio
Pace University | Undergraduate Degree |
Long Island University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Director of Finance/CFO | 5 |
Corporate Secretary | 4 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
RENOVACARE, INC. | Health Technology |
SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
CERES VENTURES, INC. | Health Services |
Bedrijven in privébezit | 2 |
---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
- Beurs
- Insiders
- Frank J. Fabio
- Ervaring